Yuyu Pharma Inc Market Cap ($13.44 Million)
Market Cap & Net Worth: Yuyu Pharma Inc (000225)
Yuyu Pharma Inc market cap. Yuyu Pharma Inc (KO:000225) has a market capitalization of $13.44 Million (₩19.84 Billion) as of November 1, 2026. Listed on the KO stock exchange, this Korea-based company holds position #26172 globally and #1961 in its home market, demonstrating a -3.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuyu Pharma Inc's stock price ₩3385.00 by its total outstanding shares 5859680 (5.86 Million). Also see 000225 cash flow conversion for how efficiently the company converts equity into cash flow.
Yuyu Pharma Inc Market Cap History (2015–2026)
Yuyu Pharma Inc market cap history from 2015 to 2026. Data shows growth from $12.56 Million to $13.44 Million (1.28% CAGR). Check today's stock price for Yuyu Pharma Inc for real-time trading data and today's change.
Yuyu Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuyu Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000225 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Yuyu Pharma Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Yuyu Pharma Inc's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.39 Million | $71.58 Billion | $5.89 Billion | 0.00x | 0.00x |
| 2017 | $12.24 Million | $62.85 Billion | $4.54 Billion | 0.00x | 0.00x |
| 2018 | $12.86 Million | $83.10 Billion | $4.02 Billion | 0.00x | 0.00x |
| 2019 | $13.50 Million | $90.88 Billion | $4.72 Billion | 0.00x | 0.00x |
| 2020 | $26.81 Million | $98.12 Billion | $1.28 Billion | 0.00x | 0.02x |
| 2021 | $37.89 Million | $115.66 Billion | -$2.21 Billion | 0.00x | N/A |
| 2022 | $30.50 Million | $138.88 Billion | -$5.99 Billion | 0.00x | N/A |
| 2023 | $23.87 Million | $137.21 Billion | -$7.18 Billion | 0.00x | N/A |
| 2024 | $17.79 Million | $133.15 Billion | $8.72 Billion | 0.00x | 0.00x |
| 2025 | $20.61 Million | $140.88 Billion | $8.15 Billion | 0.00x | 0.00x |
Competitor Companies of 000225 by Market Capitalization
Companies near Yuyu Pharma Inc in the global market cap rankings as of November 1, 2026. Also see Yuyu Pharma Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Yuyu Pharma Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Yuyu Pharma Inc (2015–2026)
Market capitalization of Yuyu Pharma Inc from 2015 to today. Between 2015 and today, Yuyu Pharma Inc's market cap moved from $12.56 Million to $ 13.44 Million, with a yearly change of 1.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩13.44 Million | -34.78% |
| 2025 | ₩20.61 Million | +15.85% |
| 2024 | ₩17.79 Million | -25.46% |
| 2023 | ₩23.87 Million | -21.74% |
| 2022 | ₩30.50 Million | -19.52% |
| 2021 | ₩37.89 Million | +41.36% |
| 2020 | ₩26.81 Million | +98.56% |
| 2019 | ₩13.50 Million | +4.97% |
| 2018 | ₩12.86 Million | +5.07% |
| 2017 | ₩12.24 Million | +17.76% |
| 2016 | ₩10.39 Million | -17.27% |
| 2015 | ₩12.56 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Yuyu Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.44 Million USD |
| MoneyControl | $13.44 Million USD |
| MarketWatch | $13.44 Million USD |
| marketcap.company | $13.44 Million USD |
| Reuters | $13.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more